OVERSEA CHINESE BANKING Corp Ltd Sells 4,810 Shares of Lam Research Corporation $LRCX

Key Points

• OVERSEA CHINESE BANKING Corp Ltd cut its stake in Lam Research by 66.6%, selling 4,810 shares and leaving it with 2,413 shares valued at about $413,000.
• Lam Research beat Q3 expectations with $1.47 EPS (vs. $1.36 est.) and $5.84B revenue (+23.8% YoY), issued Q4 EPS guidance of $1.50–1.80, and prompted multiple analysts to raise price targets.
• Notable insider selling occurred recently: CFO Douglas Bettinger sold 50,057 shares (~$11.2M) and insiders have sold 130,886 shares (~$29.7M) in the last 90 days, though insiders still hold 0.31% of the stock.

OVERSEA CHINESE BANKING Corp Ltd decreased its stake in Lam Research Corporation (NASDAQ:LRCX - Free Report) by 66.6% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,413 shares of the semiconductor company's stock after selling 4,810 shares during the period. OVERSEA CHINESE BANKING Corp Ltd's holdings in Lam Research were worth $413,000 as of its most recent filing with the SEC.

Several other hedge funds have also added to or reduced their stakes in LRCX. PMV Capital Advisers LLC bought a new stake in shares of Lam Research in the fourth quarter valued at approximately $25,000. Stance Capital LLC bought a new stake in shares of Lam Research in the third quarter valued at approximately $26,000. Triumph Capital Management bought a new stake in shares of Lam Research in the third quarter valued at approximately $27,000. Strategic Wealth Investment Group LLC bought a new stake in shares of Lam Research in the second quarter valued at approximately $29,000. Finally, Measured Wealth Private Client Group LLC bought a new stake in shares of Lam Research in the third quarter valued at approximately $40,000. Institutional investors own 84.61% of the company's stock.

Lam Research Stock Performance

Lam Research stock opened at $258.56 on Friday. The firm's 50 day simple moving average is $234.34 and its 200 day simple moving average is $197.02. The company has a current ratio of 2.26, a quick ratio of 1.61 and a debt-to-equity ratio of 0.37. The firm has a market capitalization of $322.88 billion, a PE ratio of 48.78, a price-to-earnings-growth ratio of 2.83 and a beta of 1.78. Lam Research Corporation has a 1-year low of $67.55 and a 1-year high of $273.50.

Lam Research (NASDAQ:LRCX - Get Free Report) last posted its earnings results on Wednesday, April 22nd. The semiconductor company reported $1.47 earnings per share for the quarter, topping analysts' consensus estimates of $1.36 by $0.11. The business had revenue of $5.84 billion for the quarter, compared to analyst estimates of $5.70 billion. Lam Research had a net margin of 30.94% and a return on equity of 67.07%. Lam Research's revenue was up 23.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.04 EPS. Lam Research has set its Q4 2026 guidance at 1.500-1.800 EPS. As a group, analysts expect that Lam Research Corporation will post 5.29 earnings per share for the current fiscal year.

Lam Research Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, April 8th. Investors of record on Wednesday, March 4th were issued a dividend of $0.26 per share. This represents a $1.04 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend was Wednesday, March 4th. Lam Research's dividend payout ratio is 21.31%.

Insider Buying and Selling

In related news, CFO Douglas R. Bettinger sold 50,057 shares of the company's stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $224.03, for a total transaction of $11,214,269.71. Following the sale, the chief financial officer owned 1,081,705 shares of the company's stock, valued at approximately $242,334,371.15. This represents a 4.42% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Eric Brandt sold 35,000 shares of the business's stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $225.60, for a total transaction of $7,896,000.00. Following the completion of the transaction, the director directly owned 253,705 shares of the company's stock, valued at approximately $57,235,848. This represents a 12.12% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 130,886 shares of company stock valued at $29,658,802. Company insiders own 0.31% of the company's stock.

Wall Street Analysts Forecast Growth

LRCX has been the topic of several research reports. TD Cowen boosted their price target on shares of Lam Research from $290.00 to $340.00 and gave the company a "buy" rating in a research report on Thursday. Wells Fargo & Company boosted their price target on shares of Lam Research from $290.00 to $320.00 and gave the company an "overweight" rating in a research report on Thursday. HSBC boosted their price target on shares of Lam Research from $181.00 to $221.00 and gave the company a "hold" rating in a research report on Friday, January 30th. BNP Paribas Exane boosted their price target on shares of Lam Research from $250.00 to $260.00 and gave the company a "neutral" rating in a research report on Thursday. Finally, Morgan Stanley boosted their price target on shares of Lam Research from $254.00 to $260.00 and gave the company an "equal weight" rating in a research report on Monday, April 6th. Twenty-six analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $281.78.

Lam Research News Summary

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Q3 beat and upbeat guidance — Lam reported $1.47 EPS and $5.84B revenue (both above expectations) and issued FYQ4 EPS guidance of $1.50–1.80 and revenue guidance above consensus, underpinning the bullish case on AI-driven equipment demand. Press Release
• Positive Sentiment: Wall Street raises targets — Dozens of firms raised price targets and kept buy/overweight ratings (e.g., JPMorgan, BofA, Bernstein, TD Cowen, Susquehanna), signaling renewed analyst conviction in a multi-year wafer‑fab equipment cycle. JPMorgan Target Coverage
• Positive Sentiment: AI / memory tailwinds — Coverage and commentary highlight AI-driven demand (incl. record support sales and memory/DRAM tightness) as a structural revenue and margin driver for Lam’s tools. Deep Dive
• Neutral Sentiment: Analyst detail & metrics — Earnings coverage (Zacks, Seeking Alpha transcripts, slide deck) gives deeper look at backlog, margins and inventory improvements; useful for modeling but not immediately directional. Zacks Analysis
• Neutral Sentiment: Industry supply commentary — Analysts and industry voices (SemiAnalysis) argue DRAM and AI demand could outpace capacity, which supports long‑term demand but also increases cyclicality and capex timing uncertainty. DRAM Demand Article
• Negative Sentiment: Valuation concerns / profit‑taking — Several pieces question whether the run (roughly +300% Y/Y) has priced in too much; some investors are trimming positions given rich multiples and rapid price appreciation. Is It Too Late?
• Negative Sentiment: Analyst caution on price vs. fundamentals — Commentary like Seeking Alpha’s note flags the AI upcycle but argues the stock may be expensive relative to expected returns, a reason for near‑term downside pressure. SA Valuation Piece

Lam Research Company Profile

Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.